Search
Menu
Home
HTB
2005
December
HTB
December 2005
Contents
Editorial
Volume 6 Number 11/12 November/December 2005
Conference reports
7th Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, 13-16 November 2005, Dublin, Ireland
Monitoring side effects in resource limited countries
Uridine supplement reverses thymidine-induced lipoatrophy
Pravastatin increases limb fat in HIV-positive patients with hypercholesterolaemia
Evidence that facial fat can return after switching from either d4T or AZT, to abacavir or tenofovir
Niacin has beneficial effect on lipids but no reduction in abdominal fat
Gluteal implants used to replace lost buttock fat
10th European AIDS Conference, 17-20 November 2005, Dublin, Ireland
Pregnancy studies at EACS
Antiretrovirals
Named-patient access programme available in UK for new protease inhibitor darunavir (TMC114)
Tibotec discontinues TMC125 study C227: phase III studies continue
New Kaletra tablet formulation (meltrex) approved by FDA
GSK closes phase 3 studies of its CCR5 inhibitor aplaviroc and terminates development programme
Schering discontinues phase 2 studies of vicriviroc in treatment naive patients
FDA issues approvable letter for Bioject needle-free injection device
Improved clinical outcome in 80% patients who modified an NNRTI or PI dose following therapeutic drug monitoring (TDM)
Treatment access
Brazil’s deal with Abbott is challenged in courts
Pregnancy
US pregnancy guidelines updated (Dec 2005)
Drug resistance
Cost effectiveness of resistance testing for treatment-naive patients
Other news
European activists denounce pricing increases for HIV drugs as ‘unbearable’
On the web
Guidelines for the use of antiretroviral agents in pediatric HIV infection
American Association For The Study of Liver Diseases (AASLD), November 11-15, 2005 San Francisco
Medscape articles and online papers
Community newsletters and journals
HIV inSite Knowledge Base
Amedeo HIV Medicine
PDFs
Volume 6 Number 11/12 November/December 2005 PDF
HTB RSS
Early access
Bipolar disorder in people living with HIV
31 October 2024
Management of drug resistance to integrase inhibitors: results from an international perinatal virtual clinic
29 October 2024
Mpox breakthrough cases after two doses of the MVA-BN vaccine
29 October 2024
All early access reports
Current issues
October 2024
September 2024
August 2024
Back issues
Special report
HIV diagnoses in England jump by 51% in 2023: missing targets and highlighting disparities in access to care
6 October 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate